NICE

News

NICE backs use of post-stroke genetic testing

NICE has launched a new consultation on the use of CYP2C19 genotype testing to guide treatment after a stroke or transient ischaemic attack (TIA) or ‘mini-stroke’.

News

NICE endorses use of digital therapies for psychosis

Three digital health technologies (DHTs) used to support patients with psychosis can be used by the NHS while additional evidence of their benefits is gathered.

Market Access

Do better: The message to the industry from an analysis of c...

Dr Leeza Osipenko and colleagues analysed the quality of clinical evidence submitted by companies to NICE technology appraisals (TAs) over the last 20 years.

News

Pfizer’s Velsipity heading for NHS use in ulcerative colitis

Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use

News

NICE no follows Scottish aye for rare disease drug Xenpozyme

NICE has turned down Sanofi’s Xenpozyme as a treatment for the rare disease acid sphingomyelinase deficiency (ASMD), creating a situation where access to the drug in the U

News

Surprise Enhertu rejection follows NICE process change

NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described

NICE backs use of post-stroke genetic testing

NICE endorses use of digital therapies for psychosis

Do better: The message to the industry from an analysis of c...

Pfizer’s Velsipity heading for NHS use in ulcerative colitis

NICE no follows Scottish aye for rare disease drug Xenpozyme

Surprise Enhertu rejection follows NICE process change

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

NICE

Editor's Picks